Literature DB >> 3552299

Why patients with heart failure die: hemodynamic and functional determinants of survival.

J A Franciosa.   

Abstract

The high mortality of heart failure is associated with hemodynamic abnormalities, depressed cardiac function, and reduced exercise capacity. That these factors can be modified by drug treatment is of potential prognostic significance. Hemodynamic variables are related to survival, and long-term prognosis is better in patients with only midly abnormal cardiac output or ventricular filling pressures. Indexes of left ventricular function such as ejection or shortening fraction tend to be higher in patients who survive for longer periods. The relation between exercise capacity and survival, however, is unclear. Those patients with severe exercise intolerance (maximal oxygen uptake below 10 ml/min/kg) or with severe symptoms are at great risk of dying. However, exercise capacity and functional class are not related to prognosis when all classes of patients are considered together, especially if class IV patients are excluded. Most of the available data derive from retrospective analyses of trials involving heterogeneous patient populations and aimed at improving left ventricular performance or functional capacity. Large prospective trials aimed primarily at affecting mortality in a broad spectrum of patients are needed to learn more about determinants of survival in heart failure.

Entities:  

Mesh:

Year:  1987        PMID: 3552299

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  5 in total

1.  Factors determining angiotensin-converting enzyme inhibitor underutilization in heart failure in a community setting.

Authors:  E F Philbin
Journal:  Clin Cardiol       Date:  1998-02       Impact factor: 2.882

2.  Prognostic significance of electrocardiographic findings in patients with dilated cardiomyopathy.

Authors:  Y Koga; T Wada; H Toshima; K Akazawa; Y Nose
Journal:  Heart Vessels       Date:  1993       Impact factor: 2.037

Review 3.  The management of heart failure: a matter of definition?

Authors:  A Harley
Journal:  Cardiovasc Drugs Ther       Date:  1993-08       Impact factor: 3.727

4.  Cardiac Index by Transthoracic Echocardiography (CITE) study.

Authors:  Barna Szabó; Eszter Krisztina Marosi; Katarina Vargová; Noémi Nyolczas
Journal:  PLoS One       Date:  2018-12-12       Impact factor: 3.240

Review 5.  What is treatment success in cardiac resynchronization therapy?

Authors:  Paul W X Foley; Francisco Leyva; Michael P Frenneaux
Journal:  Europace       Date:  2009-11       Impact factor: 5.214

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.